medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2015, Number 3

<< Back Next >>

Ann Hepatol 2015; 14 (3)

Exercise capacity of cirrhotic patients with hepatopulmonary syndrome

Faustini-Pereira JL, Homercher-Galant L, Garcia E, Bandeira de Mello BA, Marroni CA

Language: English
References: 31
Page: 361-368
PDF size: 116.30 Kb.


ABSTRACT

Introduction. Hepatopulmonary syndrome (HPS) is characterized by a clinical triad of liver disease and/or portal hypertension, intrapulmonary vascular dilatation and abnormal arterial oxygenation. These conditions can worsen muscle strength, exercise capacity and functionality in the affected population. Objective. The objective of this study was to compare exercise capacity, functional condition and respiratory muscle strength in cirrhotic patients diagnosed with HPS and cirrhotic patients without this diagnosis. Material and methods. This cross-sectional study used a convenience sample consisting of 178 patients (92 patients with HPS and 86 patients without HPS) with a diagnosis of liver cirrhosis caused by either alcohol consumption or the hepatitis C virus (HCV). Peak oxygen consumption (VO2 peak) was used to verify exercise capacity, the six-minute walk test (6MWT) was used to test functionality, and manovacuometry was used to evaluate the strength of the respiratory muscles. The Kolmogorov-Smirnov test and Student’s t-test were used for the statistical analysis. The data were analyzed using SPSS 16.00, and p ‹ 0.05 was considered significant. Results. The group of patients with the diagnosis of HPS exhibited a lower VO2 peak (14.2 ± 2.3 vs. 17.6 ± 2.6, p ‹ 0.001), shorter distance walked in the 6MWT (340.8 ± 50.9 vs. 416.5 ± 91.4, p ‹ 0.001), lower maximal inspiratory pressure (-49.1 ± 9.8 vs. -74.2 ± 13.9, p = 0.001) and lower maximum expiratory pressure (60.1 ± 12.2 vs. 76.8 ± 14.7, p = 0.001). Conclusion. The group of cirrhotic patients diagnosed with HPS exhibited lower values for VO2 peak, distance walked in the 6MWT and respiratory muscle strength than the cirrhotic patients not diagnosed with HPS.


REFERENCES

  1. Lida VH, da Silva TJA, da Silva ASF, da Silva LFF, Alves VAF. Cirrose hepática: Aspectos morfológicos relacionados às suas possíveis complicações. Um estudo baseado em necrópsias. J Bras Patol Med Lab 2005; 41: 29-36.

  2. Younossi ZM, Guyatt. Quality-of-Life Assesments and Chronic Liver Disease. Am J Gastroenterol 2006; 93: 1037-41.

  3. Younossi ZM. Chronic liver disease and health-related quality of life. Gastroenterology 2001; 120: 305-7.

  4. Van den Plas SM, Hansen BE, de Boer JB. Generic and disease- specific health related quality of life in non-cirrhotic, cirrhotic and transplanted liver patients: a cross-sectional study. BMC Gastroenterol 2003; 3: 33.

  5. Gutteling JJ, de Man RA, Kiwi M, Boparai N, King D. Determinants of quality of life in chronic liver patients. Aliment Pharmacol Ther 2006; 23: 1629-35.

  6. Carrithers RL. Liver Transplantation. Liver Transpl 2000; 6: 122-35.

  7. Dickson RC, Wright RM, Bacchetta MD, Bacchetta MD, Bodiky SE, Caldwell SH, Driscoll CL. Quality of life of hepatitis B and C patients after liver transplantation. Clin Transplant 1997; 11: 282-5.

  8. Robinson LR, Switala J, Tarter RE, Nicholas JJ. Fuctional Outcome After Liver Transplantation. Arch Phys Med Rehabil 2000; 71: 426-7.

  9. Miyamoto S, Nagaya N, Satoh T, Kyotani S, Sakamaki F, Fujita M, Nakanishi N, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension: comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000; 161: 487-92.

  10. Abrams GA, Jaffe CC, Hoffer PB, Binder HJ. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 1995; 109: 1283-8.

  11. Krowka MJ, Dickson ER, Cortese DA. Hepatopulmonary Syndrome: clinical observations and lack of therapeutic response to somatostatin analogue. Chest 1993; 104: 515-21.

  12. Garcia E. Alterações na função pulmonar secundárias a cirrose hepática (Dissertação). Porto Alegre: Universidade Federal do Rio Grande do Sul, 1995.

  13. Agusti AGN, Roca J, Bosch J, Rodriguez-Roisin R. The lung in patients with cirrhosis. J Hepatol 1990; 10: 251-7.

  14. Aguilar MP, Altamirano JT, Torre-Delgadilho A, Charlton MR, Duarte-Rojo A. Porto Pulmonary Hypertension and Hepatopulmonary syndrome: a clinican-oreiented overview. Eur Respir Rev 2012; 21: 223-33.

  15. Lima B, Martinelli A, França AVC. Sídrome Hepatopulmonar: Patogenia, diagnóstico e tratamento. Arq Gastroenterol 2004; 41: 250-8.

  16. American College of Sports Medicine. Guidelines for Exercise Testing and Prescription, 5th ed. Philadelphia: Williams & Wilkins, 1995.

  17. Brooks D, Solway S, Gibbons WJ. ATS Statemant on six minute walk test. Am J Resp Crit Care Med 2003; 167: 1287.

  18. Sociedade Brasileira de Pneumologia e Tisiologia. Diretrizes para Testes de Função Pulmonar. J Pneumol 2002; 28.

  19. Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Resp Dis 1969; 99: 696-702.

  20. Paul LE, Duane LS. Reference Equations for the Six-Minute Walk in Healthy Adults. Respiratory and Critical Care Medicine 1998; 158: 1384-7.

  21. Dharancy S, Lemyze M, Boleslawski E, Neviere R, Declerck N, Canva V, Wallaert B, et al. Impact of Impaired Aerobic Capacity on Liver Transplant Candidates. Transplantation 2008; 86: 1077-83.

  22. Galant LH, Forgiarini Junior LA, Dias AS, Marroni CA. Maximum Oxygen Consumption Predicts Mortality in Patients with Alcoholic Cirrhosis. Hepato-Gastroenterology 2013; 60: 1127-30.

  23. Carey EJ, Steidley DE, Aqel BA, Byrne TJ, Mekeel KL, Rakela J, Vargas HE, et al. Six Minute Walk Distance Predicts Mortality in Liver Transplant Candidates. Liver Transplantation 2010; 16: 1373-8.

  24. Faustini JL, Figueredo TCM, Galant LH, Forgiarini Junior LA, Dias AS, Monteiro MB, Marroni CA. Funcional Capacity and Respiratory Muscle Strenght of Candidates to Hepatic Transplant. Rev Bras Med Esporte 2011; 17: 315-8. Faustini Pereira JL, et al. , 2015; 14 (3): 361-368 368

  25. Alameri HF, Sanai FM, Al Dukhayil M, Azzam NA, Al-Swat KA, Hersi AS, Abdo AA. Six minute walk test to asses fuctional capacity in chronic liver disease patients. World J Gastroenterol 2007; 13: 3996-4001.

  26. Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 2001; 119: 256-70.

  27. Cahalin L, Pappagianopoulos P, Prevost S, Wain J, Ginns L. The relationship of the 6-min walk test to maximal oxygen consumption in transplant candidates with end-stage lung disease. Chest 1995; 108: 452-9.

  28. Galant LH, Forgiarini Junior LA, Dias AS, Marroni CA. Condição Funcional, Força Muscular Respiratória e Qualidade de Vida em Pacientes Cirróticos. Revista Brasileira de Fisioterapia 2012; 16: 30-4.

  29. Carvalho EM, Iserm MRM, Lima PA, Machado CS, Biaagini AP, Massarollo PCB. Força muscular e mortalidade na lista de espera de transplante de fígado. Rev Bras Fisioter 2008; 12: 235-40.

  30. Fallon MB, Krowka MJ, Brown RS, Trotter JF, Zacks S, Roberts KE, Shah VH, et al. Impact of Hepatopulmonary Syndrome on Quality of Life and Survival in Liver Transplant Candidates. Gastroenterology 2008; 135: 1168-75.




2020     |     www.medigraphic.com